This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser.
Print Document
View Excel Document
Financial Statements
Condensed Balance Sheets
Condensed Balance Sheets (Parenthetical)
Consolidated Statements of Operations and Comprehensive Loss
Consolidated Statements of Stockholders' Equity
Consolidated Statements of Cash Flows
Notes to Financial Statements
Organization and Basis of Presentation
Summary of Significant Accounting Policies
Fair Value Measurements
Short-Term Investments
Accrued Other Expenses
Convertible Preferred Stock and Stockholders' Equity (Deficit)
Agreements with Arena Pharmaceuticals, Inc.
Stock-Based Compensation
Commitments and Contingencies
Income Taxes
Employment Benefits
Accounting Policies
Summary of Significant Accounting Policies (Policies)
Notes Tables
Summary of Significant Accounting Policies (Tables)
Fair Value Measurements (Tables)
Short-Term Investments (Tables)
Accrued Other Expenses (Tables)
Agreements with Arena Pharmaceuticals, Inc (Tables)
Stock-Based Compensation (Tables)
Commitments and Contingencies (Tables)
Income Taxes (Tables)
Notes Details
Organization and Basis of Presentation - Additional Information (Details)
Summary of Significant Accounting Policies - Additional Information (Details)
Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)
Fair Value Measurements (Additional Information) (Details)
Fair Value Measurements - Summary of Company's Financial Assets Recognized at Fair Value (Details)
Short-Term Investments - Summary of Short-Term Investments (Details)
Short-Term Investments (Additional Information) (Details)
Short-Term Investments - Summary of Maturity of the Short-Term Investments (Details)
Accrued Other Expenses - Summary of Accrued Other Expenses (Details)
Convertible Preferred Stock and Stockholders' Equity (Deficit) - Additional Information (Details)
Agreements with Arena Pharmaceuticals, Inc. - Additional Information (Details)
Agreements with Arena Pharmaceuticals, Inc - Schedule of Services Expenses (Details)
Stock-Based Compensation - Additional Information (Details)
Stock-Based Compensation - Summary of Stock Option Activity (Details)
Stock-Based Compensation - Summary of Weighted Average Grant-Date Fair Values And Weighted Average Assumptions Used to Calculate Fair Value of Options Granted (Details)
Stock-Based Compensation Expense - Schedule of Stock-Based Compensation Expense Recognized for all Equity Awards and Reported in the Statements of Operations and Comprehensive Loss (Details)
Commitments and Contingencies - Additional Information (Details)
Commitments and Contingencies - Schedule of Supplemental Cash Flow Information Related to Leases (Details)
Commitments and Contingencies - Schedule of Supplemental Balance Sheet Information Related to Leases (Details)
Commitments and Contingencies - Schedule of Future Minimum Lease Commitments (Details)
Income Taxes - Net loss Attributable To Stockholders Before Benefit for Income Taxes (Details)
Income Taxes - Schedule of Provision For Income Taxes and Income Taxes Computed U.S. Federal Statutory Corporate Tax Rate (Details)
Income Taxes - Schedule of Components of Deferred Taxes (Details)
Income Taxes - Summery of Beginning and Ending Amounts of Unrecognized Tax Benefits (Details)
Income Taxes - Additional Information (Details)
Employment Benefits - Additional Information (Details)
All Reports